Healthcare has enjoyed a surge in M&A activity over the past year as more pharmaceutical and medical technology players acquire to boost growth. In this highly competitive sector for M&A and strategic advisory, Citigroup has risen from 10th place in the 2021 buyside league to first in 2025, according to Dealogic. “There were 11 healthcare M&A deals worth more than $1bn in enterprise value last year,” says Chuck Adams, global head of Citi’s healthcare, consumer and retail group. “We advised on seven of them.” Citi’s nearest competitor was on four.
Read the full article: Citi’s Strong Bill of M&A Healthcare Deals //
Source: https://www.thebanker.com/content/f294f8c4-2eef-405d-8f44-766cbe8590d1